We are live on ! Find out more
GTHX

G1 Therapeutics, Inc. Common Stock
GTHX

Delisted

GTHX was delisted on the 17th of September, 2024.

Back to rankings

93 hedge funds and large institutions have $525M invested in G1 Therapeutics, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 39 increasing their positions, 30 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 30

19% less funds holding

Funds holding: 115 → 93 (-22)

59% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 37

62% less capital invested

Capital invested by funds: $1.39B → $525M (-$864M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
93
Holders Change
-22
Holders Change %
-19.13%
% of All Funds
2.07%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
15
Increased
39
Reduced
30
Closed
37
Calls
–
Puts
$1K
Net Calls
-$1K
Net Calls Change
+$669K

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$21M
2
JP Morgan Chase
JP Morgan Chase
New York
+$18.7M
3
State Street
State Street
Massachusetts
+$14.7M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$13.5M
5
CAM
Cormorant Asset Management
Massachusetts
+$13.3M

Top Sellers

Rank Fund Capital Flow
1
HIM
Hillhouse Investment Management
Cayman Islands
-$49.6M
2
EA
Emerald Advisers
Pennsylvania
-$25.4M
3
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$24.8M
4
DM
Deerfield Management
New York
-$15M
5
MCM
Marsico Capital Management
Colorado
-$10.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
26
Citigroup
New York
$2.16M +$2.91M +77,821 +224%
RSCM
27
Rock Springs Capital Management
Maryland
$1.92M -$4.98M -133,073 -57%
UBS Group
28
UBS Group
Switzerland
$1.8M +$3.24M +86,380 +1,113%
Goldman Sachs
29
Goldman Sachs
New York
$1.71M -$26.4K -705 -0.8%
MWNA
30
Marshall Wace North America
New York
$1.7M +$3.11M +83,055 +1,419%
AA
31
ALPS Advisors
Colorado
$1.65M +$1M +26,817 +45%
Dimensional Fund Advisors
32
Dimensional Fund Advisors
Texas
$1.57M +$3.07M +81,970 New
Two Sigma Investments
33
Two Sigma Investments
New York
$1.45M +$2.84M +75,857 New
USAA
34
United Services Automobile Association
Texas
$1.3M -$163K -4,345 -6%
Squarepoint
35
Squarepoint
New York
$1.19M +$1.18M +31,498 +102%
SG Americas Securities
36
SG Americas Securities
New York
$970K +$1.9M +50,635 New
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$918K -$112K -3,000 -6%
Deutsche Bank
38
Deutsche Bank
Germany
$911K -$1.09M -29,151 -38%
TA
39
Teachers Advisors
New York
$861K +$87.9K +2,348 +6%
TD Asset Management
40
TD Asset Management
Ontario, Canada
$814K -$159K -4,252 -9%
Swiss National Bank
41
Swiss National Bank
Switzerland
$735K +$48.7K +1,300 +4%
ARTA
42
A.R.T. Advisors
New York
$730K +$939K +25,078 +192%
S
43
SignatureFD
Georgia
$727K +$637K +17,000 +81%
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$683K +$142K +3,785 +12%
Ameriprise
45
Ameriprise
Minnesota
$654K +$1.28M +34,122 New
Invesco
46
Invesco
Georgia
$634K -$3.95M -105,489 -76%
SCA
47
Secor Capital Advisors
New York
$624K +$1.22M +32,591 New
AQR Capital Management
48
AQR Capital Management
Connecticut
$622K +$503K +13,424 +70%
TCIM
49
TIAA CREF Investment Management
New York
$617K -$38K -1,014 -3%
AllianceBernstein
50
AllianceBernstein
Tennessee
$559K -$26.2K -700 -2%
1
2
3 4 5

GTHX Hedge Fund Activity: Q4 2018 in Review

93 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in G1 Therapeutics, Inc. Common Stock (GTHX) for Q4 2018, worth a combined $525M — down 62% from $1.39B a quarter earlier.

Sellers outnumbered buyers: 37 funds closed out of GTHX and 15 opened new positions — a net loss of 22 holders — while 30 trimmed existing stakes and 39 added.

The largest buyer was Wellington Management Group, adding an estimated $21M. The largest seller was Hillhouse Investment Management, exiting entirely with an estimated $49.6M sold.

  • 93 institutional investors held G1 Therapeutics, Inc. Common Stock (GTHX) as of Q4 2018, down from 115 in Q3 2018.
  • Funds reported $525M of G1 Therapeutics, Inc. Common Stock stock for Q4 2018, down 62% quarter-over-quarter.
  • 15 funds opened new G1 Therapeutics, Inc. Common Stock positions in Q4 2018 and 37 closed out, a net change of -22 holders.
  • The largest G1 Therapeutics, Inc. Common Stock buyer in Q4 2018 was Wellington Management Group, an estimated $21M added.
  • The largest G1 Therapeutics, Inc. Common Stock seller in Q4 2018 was Hillhouse Investment Management, an estimated $49.6M sold.

Based on aggregated 13F filings for Q4 2018.